The FASEB Journal, Vol 2, 2774-2783, Copyright © 1988 by The Federation of American Societies for Experimental Biology

REVIEWS

Disruption of hepatic heme biosynthesis after interaction of xenobiotics with cytochrome P-450

GS Marks, SA McCluskey, JE Mackie, DS Riddick and CA James
Department of Pharmacology and Toxicology, Queen's University, Kingston, Ontario, Canada.

Heme biosynthesis in hepatocytes is controlled by a free heme pool, which regulates delta-aminolevulinic acid synthase. Porphyrinogenic chemicals deplete the regulatory free heme pool by interacting with cytochrome P-450 thereby inhibiting heme biosynthesis and/or causing heme breakdown. Recent developments allow us to predict which groups of chemicals are likely to be porphyrinogenic. One group is exemplified by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine. Heterocyclic compounds of this type cause mechanism-based inactivation of cytochrome P-450, leading to the formation of N-alkylporphyrins, with ferrochelatase-inhibitory activity resulting in lowering the free heme pool. Allylisopropylacetamide exemplifies a second group. Such compounds containing a terminal olefinic or acetylenic group, cause mechanism-based inactivation of cytochrome P-450. In the process, the heme moiety of cytochrome P-450 is destroyed and the free heme pool is lowered. A third group is exemplified by planar polyhalogenated or polycyclic aromatic hydrocarbons. These compounds induce specific cytochrome P-450 isozymes but are poor substrates. Active oxygen is formed, which interacts with a hepatic substrate to form a uroporphyrinogen decarboxylase inhibitor. Inhibition of this enzyme leads to depletion of the free heme pool.

This article has been cited by other articles:

				J. T. Gamble, K. Nakatsu, and G. S. Marks Comparison of the Formation of N-Alkylprotoporphyrin IX after Interaction of Porphyrinogenic Xenobiotics with Single cDNA-Expressed Human P450 Enzymes in Microsomes Prepared from Baculovirus-Infected Insect Cells and Human Lymphoblastoid Cell Lines+ Drug Metab. Dispos., February 1, 2003; 31(2): 202 - 205. [Abstract] [Full Text] [PDF]

				J. A. Lavigne, K. Nakatsu, and G. S. Marks Identification of Human Hepatic Cytochrome P450 Sources of N-alkylprotoporphyrin IX after Interaction with Porphyrinogenic Xenobiotics, Implications for Detection of Xenobiotic-Induced Porphyria in Humans Drug Metab. Dispos., July 1, 2002; 30(7): 788 - 794. [Abstract] [Full Text] [PDF]

				S. G. W. Wong, E. H. Lin, and G. S. Marks Cytochrome CYP Sources of N-Alkylprotoporphyrin IX after Administration of Porphyrinogenic Xenobiotics to Rats Drug Metab. Dispos., September 1, 1999; 27(9): 960 - 965. [Abstract] [Full Text]

				S. G.W. Wong, S. M. Kobus, J. P. McNamee, and G. S. Marks Gender Differences in N-Alkyl Protoporphyrin IX Production in Rats after the Administration of Porphyrinogenic Xenobiotics Drug Metab. Dispos., August 1, 1998; 26(8): 739 - 744. [Abstract] [Full Text]

				J. P. McNamee, M. Jurima-Romet, S. M. Kobus, and G. S. Marks cDNA-Expressed Human Cytochrome P450 Isozymes. Inactivation by Porphyrinogenic Xenobiotics Drug Metab. Dispos., April 1, 1997; 25(4): 437 - 441. [Abstract] [Full Text]

				P Ponka Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells Blood, January 1, 1997; 89(1): 1 - 25. [Abstract] [Full Text]